Financial Information [Management's Discussion and Analysis of Financial Condition and Results of Operations](index=5&type=section&id=Management%27s%20Discussion%20and%20Analysis%20of%20Financial%20Condition%20and%20Results%20of%20Operations) This section provides an overview of Morgan Stanley's financial performance, business segments, and key financial metrics for the quarter and six months ended June 30, 2025 [Introduction](index=5&type=section&id=Introduction) Morgan Stanley is a global financial services firm operating across Institutional Securities, Wealth Management, and Investment Management segments, offering diverse products and services to a broad client base - Morgan Stanley operates in three main business segments: Institutional Securities, Wealth Management, and Investment Management, providing a wide array of financial products and services to corporations, governments, financial institutions, and individuals[12](index=12&type=chunk) - Future results may be materially affected by competition, legislative, legal, and regulatory developments, and other risk factors[17](index=17&type=chunk) [Executive Summary](index=6&type=section&id=Executive%20Summary) Morgan Stanley reported strong financial results for Q2 2025 and YTD 2025, with significant increases in net revenues, net income, and diluted EPS | Metric | Q2 2025 ($ millions) | Q2 2024 ($ millions) | % Change (QoQ) | | :-------------------------------- | :------------------- | :------------------- | :--------------- | | Net Revenues | $16,800 | $15,000 | 12% | | Net Income Applicable to Morgan Stanley | $3,500 | $3,100 | 15% | | Diluted EPS | $2.13 | $1.82 | 17% | | Metric | YTD 2025 ($ millions) | YTD 2024 ($ millions) | % Change (YoY) | | :-------------------------------- | :------------------- | :------------------- | :--------------- | | Net Revenues | $34,500 | $30,200 | 15% | | Net Income Applicable to Morgan Stanley | $7,900 | $6,500 | 21% | | Diluted EPS | $4.73 | $3.85 | 23% | - The Firm delivered ROE of **13.9%** and ROTCE of **18.2%** for Q2 2025. The expense efficiency ratio was **71%** for Q2 and **70%** YTD, reflecting cost discipline and productivity gains[25](index=25&type=chunk) - Institutional Securities reported **$7.6 billion** in net revenues, driven by strong Markets business performance, especially in Equity. Wealth Management delivered a pre-tax margin of **28.3%** with **$7.8 billion** in net revenues, boosted by higher Asset management and Transactional revenues, adding **$59 billion** in net new assets. Investment Management saw **$1.6 billion** in net revenues, primarily from asset management fees on higher AUM[25](index=25&type=chunk) Selected Financial Information and Other Statistical Data | Metric | Q2 2025 | Q2 2024 | YTD 2025 | YTD 2024 | | :-------------------------------- | :------ | :------ | :------- | :------- | | Net revenues ($ millions) | 16,792 | 15,019 | 34,531 | 30,155 | | Earnings applicable to common shareholders ($ millions) | 3,392 | 2,942 | 7,549 | 6,208 | | Earnings per diluted common share | 2.13 | 1.82 | 4.73 | 3.85 | | Expense efficiency ratio | 71% | 72% | 70% | 72% | | ROE | 13.9% | 13.0% | 15.7% | 13.8% | | ROTCE | 18.2% | 17.5% | 20.6% | 18.6% | | Pre-tax margin | 28% | 27% | 29% | 28% | | Effective tax rate | 22.7% | 23.5% | 21.8% | 22.3% | | **Pre-tax margin by segment:** | | | | | | Institutional Securities | 28% | 29% | 32% | 31% | | Wealth Management | 28% | 27% | 28% | 27% | | Investment Management | 21% | 16% | 20% | 17% | | **At June 30, 2025 / Dec 31, 2024:** | | | | | | Average liquidity resources (Q2/YTD) ($ millions) | 363,389 | 345,440 | | | | Loans ($ millions) | 267,395 | 246,814 | | | | Total assets ($ millions) | 1,353,870 | 1,215,071 | | | | Deposits ($ millions) | 389,377 | 376,007 | | | | Borrowings ($ millions) | 328,801 | 288,819 | | | | Common equity ($ millions) | 98,434 | 94,761 | | | | Tangible common equity ($ millions) | 75,517 | 71,604 | | | | Common shares outstanding (millions) | 1,598 | 1,607 | | | | Book value per common share | 61.59 | 58.98 | | | | Tangible book value per common share | 47.25 | 44.57 | | | | Worldwide employees (thousands) | 80 | 80 | | | | Client assets (billions) | 8,205 | 7,860 | | | | **Capital Ratios (June 30, 2025 / Dec 31, 2024):** | | | | | | Common Equity Tier 1 capital—Standardized | 15.0% | 15.9% | | | | Tier 1 capital—Standardized | 16.9% | 18.0% | | | | Common Equity Tier 1 capital—Advanced | 15.7% | 15.7% | | | | Tier 1 capital—Advanced | 17.6% | 17.8% | | | | Tier 1 leverage | 6.8% | 6.9% | | | | SLR | 5.5% | 5.6% | | | [Economic and Market Conditions](index=9&type=section&id=Economic%20and%20Market%20Conditions) The second quarter of 2025 experienced varied market conditions, starting with economic uncertainty and market volatility due to global trade concerns, followed by a steady rebound in capital markets - Q2 2025 began with economic uncertainty and market volatility from global trade concerns, but later saw a steady rebound in capital markets[44](index=44&type=chunk) - Geopolitical uncertainty, trade policy changes, inflation, and central bank actions are identified as ongoing factors impacting capital markets and business[44](index=44&type=chunk) [Selected Non-GAAP Financial Information](index=9&type=section&id=Selected%20Non-GAAP%20Financial%20Information) The firm uses non-GAAP financial measures like adjusted net revenues, adjusted compensation expense, tangible common equity, and ROTCE to provide additional transparency and comparability of financial condition and operating results - Non-GAAP financial measures are used to provide further transparency and an alternate means of assessing financial condition, operating results, and capital adequacy, particularly by excluding the impact of mark-to-market gains and losses on DCP investments[46](index=46&type=chunk)[48](index=48&type=chunk) - Tangible common equity, ROTCE, and tangible book value per common share are non-GAAP measures considered useful for evaluating operating performance and capital adequacy, calculated by adjusting common equity for goodwill and intangible assets[50](index=50&type=chunk) Reconciliations from U.S. GAAP to Non-GAAP Consolidated Financial Measures | Metric | Q2 2025 (GAAP) | Q2 2025 (Adjusted Non-GAAP) | Q2 2024 (GAAP) | Q2 2024 (Adjusted Non-GAAP) | | :-------------------------------- | :------------- | :-------------------------- | :------------- | :-------------------------- | | Net revenues ($ millions) | $16,792 | $16,415 | $15,019 | $15,073 | | Compensation expense ($ millions) | $7,190 | $6,819 | $6,460 | $6,405 | | Wealth Management Net revenues ($ millions) | $7,764 | $7,470 | $6,792 | $6,837 | | Wealth Management Compensation expense ($ millions) | $4,147 | $3,883 | $3,601 | $3,568 | | Metric | YTD 2025 (GAAP) | YTD 2025 (Adjusted Non-GAAP) | YTD 2024 (GAAP) | YTD 2024 (Adjusted Non-GAAP) | | :-------------------------------- | :------------- | :-------------------------- | :------------- | :-------------------------- | | Net revenues ($ millions) | $34,531 | $34,303 | $30,155 | $30,022 | | Compensation expense ($ millions) | $14,711 | $14,342 | $13,156 | $12,852 | | Wealth Management Net revenues ($ millions) | $15,091 | $14,928 | $13,672 | $13,577 | | Wealth Management Compensation expense ($ millions) | $8,146 | $7,899 | $7,389 | $7,200 | | Metric | June 30, 2025 | December 31, 2024 | | :-------------------------------- | :------------ | :---------------- | | Common equity ($ millions) | $98,434 | $94,761 | | Less: Goodwill and net intangible assets ($ millions) | ($22,917

Time now for the Wall Street beat dealmakers. They are raking in billions in M&A, despite lingering fears about trade wars and about geopolitics. Transaction values are up almost a fifth this year, a $2.2% trillion, according to data compiled by Bloomberg.The latest boost to activity comes from almost 100 billion worth of deals announced in the U.S. industrial sector alone. Joining us now at the desk, Tom Miles, global co-head of M&A at Morgan Stanley. And the industrial sector was certainly one that has be ...

RT Bloomberg em Português (@BBGEmPortugues)Thomas Krautz, ex-managing director do Morgan Stanley no Brasil, foi contratado pela unidade brasileira do Banco Santander, disseram pessoas familiarizadas com o assunto https://t.co/XilJHvvu4y ...

Group 1 - Morgan Stanley maintains a bullish outlook on Tesla, naming it the top pick in the U.S. auto sector, with a price target raised to $410, indicating a potential 35% upside from the last closing price of $302 [1] - Analyst Adam Jonas highlights Tesla's leadership in areas such as artificial intelligence, robotics, energy, manufacturing, and large-scale infrastructure, noting its strong position to scale physical AI applications due to control over data and fleet operations [3] - Despite the positive outlook, Tesla faces challenges including rising competition from Chinese automakers, declining sales, and public backlash related to CEO Elon Musk's political views [4] Group 2 - Recent data shows Tesla's sales of China-made electric vehicles fell 8.4% year-over-year in July, with a total of 67,886 Model 3 and Model Y units delivered, marking a 5.2% drop from June [5] - Investors are advised to prepare for a challenging period for Tesla stock, as the company enters its historically weakest stretch of the year from August to October, although Wall Street sentiment remains positive with projections that TSLA will stay above $300 over the next 12 months [7] - The Tesla board has approved a new compensation package for Musk, which includes a 96 million share restricted stock grant valued at around $30 billion, with shares vesting after two years if Musk remains in service [8]

Market Rally & Earnings - S&P 500 自 4 月以来上涨约 30%，部分原因是关税对核心利润的影响小于预期 [5][6] - 标普 500 指数基于未来 12 个月盈利的市盈率高于 5 年和 10 年平均水平，引发了估值辩论 [7] - 德意志银行认为，尽管盈利增长，但投资者的股票配置仍处于中性水平，表明市场仍有上涨空间 [8][9] - 摩根士丹利指出，自 4 月以来，提高盈利预期的公司与降低盈利预期的公司相比，出现了 V 型复苏，表明股市上涨有基本面支撑 [3][4][5] Economic Factors & Risks - 经济学家们认为，移民限制导致的外国出生劳动力减少，可能对劳动力市场构成风险，影响工资、失业率和整体经济增长 [12][13][14][15] - 企业估值相对于经济利润而言，估值过高，与 2000 年互联网泡沫时期的情况类似 [16] - 投资者为人工智能的特殊性支付了高溢价，但如果盈利未能兑现，可能会导致股票估值过高 [21] Sector Composition & Performance - 标普 500 指数中，必需消费品、能源、医疗保健和公用事业等防御性行业的权重已从 30 年前的 40% 降至约 22% [23][24] - 巴克莱银行指出，大型科技公司的近期盈利增长超过了股价涨幅，表明如果盈利继续超出预期，这些股票可能还有上涨空间 [27][28][29]

香港联交所最新数据显示，7月24日，Morgan Stanley增持药明康德（603259）(02359)192.9554万股，每 股作价95.8573港元，总金额约为1.85亿港元。增持后最新持股数目约为2058.81万股，持股比例为 5.31%。 ...

Core Insights - NeOnc Technologies Holdings, Inc. has signed a definitive agreement for a $50 million strategic partnership with Quazar Investment, aimed at advancing treatments for brain and central nervous system cancers [2][3][4] Company Overview - NeOnc is a clinical-stage biotechnology company focused on developing therapeutics for central nervous system cancers, utilizing its proprietary NEO™ drug development platform [6] - The company has a portfolio of novel drug candidates, including NEO100™ and NEO212™, which are currently in Phase II clinical trials under FDA Fast-Track and Investigational New Drug status [6] Strategic Partnership Details - The agreement includes Quazar acquiring 1.4 million shares of NeOnc at $25 per share, totaling $35 million, with an additional $15 million allocated for Phase 2B clinical trials and infrastructure development in the UAE and MENA region [4] - Quazar plans to lead a capital formation round of up to $50 million, with 70% of proceeds directed towards acquiring NeOnc common stock and 30% for clinical trials and infrastructure [4] Future Plans and Conditions - NeOnc must fulfill certain conditions within 120 days, including the legal formation of NuroMENA and NuroCure in Abu Dhabi, for the transaction to be completed [5]

Group 1 - Morgan Stanley projects the S&P 500 to reach 7,200 by mid-2026, indicating a 12% increase from the last close of 6,389 [1] - The bullish outlook is supported by favorable economic factors, including a "rolling recovery" environment, improved operating leverage, AI adoption, a weakening U.S. dollar, and tax savings from the Inflation Reduction Act [2][4] - Anticipated interest rate cuts by the Federal Reserve in early 2026 and easing year-over-year growth comparisons further bolster the positive outlook [3] Group 2 - Oppenheimer raised its year-end S&P 500 target to 7,100 from 5,950, citing robust corporate earnings and favorable macroeconomic conditions [5] - Other institutions have also revised their forecasts upward, including BMO (6,700), Goldman Sachs (6,600), and Bank of America (6,300) [5] - Despite the bullish sentiment from many firms, Evercore ISI and HSBC remain cautious with the lowest targets at 5,600 [7]

>> WELCOME TO DAYBREAK: EUROPE. I'M JOUMANNA. AS TRADE TALKS BETWEEN THE BIGGEST ECONOMIES ROLL ON, TRUMP SAYS HIS SUMMTIT WITH XI JINPING IS "FAKE NEWS." PLUS, FIVE PEOPLE ARE KILLED IN A SHOOTING AT BLACKSTONE HEADQUARTERS IN NEW YORK.WELL, LET'S GET YOU UP TO SPEED, DEEP IN EARNINGS SEASON WITH DATA TO WATCH OUT FOR WITH META, AMAZON, MICROSOFT, BUT EUROPE, LET'S START THERE. WE THOUGHT IT WOULD BE A DAY OF GREEN BUT EUROPE WAS TRADING IN THE RED. THE DAX WAS DOWN 1% AND AUTOMAKERS WERE DOWN 3-4%.A CASE ...

Currency Analysis - Morgan Stanley advises a more cautious approach to the Turkish lira [1] - The advice is based on a faster pace of currency depreciation in Turkey [1]